XOMA
XOMA Corp
Price:  
25.18 
USD
Volume:  
35,485.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

XOMA EV/EBITDA

-190.7%
Upside

As of 2025-01-12, the EV/EBITDA ratio of XOMA Corp (XOMA) is -13.71. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. XOMA's latest enterprise value is 272.49 mil USD. XOMA's TTM EBITDA according to its financial statements is -19.87 mil USD. Dividing these 2 quantities gives us the above XOMA EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 14.0x - 15.5x 14.8x
Forward P/E multiples 14.3x - 15.2x 14.8x
Fair Price (22.08) - (23.60) (22.84)
Upside -187.7% - -193.7% -190.7%
25.18 USD
Stock Price
(22.84) USD
Fair Price

XOMA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-01-10 -13.71
2025-01-08 -14.04
2025-01-07 -14.00
2025-01-06 -14.36
2025-01-03 -14.68
2025-01-02 -14.20
2024-12-31 -14.36
2024-12-30 -14.25
2024-12-27 -14.37
2024-12-26 -14.95
2024-12-24 -14.87
2024-12-23 -14.56
2024-12-20 -14.87
2024-12-19 -13.67
2024-12-18 -13.76
2024-12-17 -14.87
2024-12-16 -15.27
2024-12-13 -14.88
2024-12-12 -15.40
2024-12-11 -16.18
2024-12-10 -16.26
2024-12-09 -16.75
2024-12-06 -16.66
2024-12-05 -16.64
2024-12-04 -17.60
2024-12-03 -17.55
2024-12-02 -18.01
2024-11-29 -18.61
2024-11-27 -18.45
2024-11-26 -18.87
2024-11-25 -17.17
2024-11-22 -16.69
2024-11-21 -16.61
2024-11-20 -16.58
2024-11-19 -16.63
2024-11-18 -16.57
2024-11-15 -16.69
2024-11-14 -16.50
2024-11-13 -16.39
2024-11-12 -17.31
2024-11-11 -17.25
2024-11-08 -17.14
2024-11-07 -16.69
2024-11-06 -18.02
2024-11-05 -17.17
2024-11-04 -17.08
2024-11-01 -16.79
2024-10-31 -16.69
2024-10-30 -16.48
2024-10-29 -17.71